Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Abbott Laboratories company logo
Abbott Laboratories logo

Abbott Laboratories (ABT) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$8.94B$972.00M+12.20%

Summary

As of today, ABT annual cash & cash equivalents is $8.94B, up +12.20% on
ABT annual cash & cash equivalents is down -12.10% over the past 3 years, up +25.06% over the past 5 years
ABT annual cash & cash equivalents is currently -52.39% below its historical high of $18.78B set on
ABT annual cash & cash equivalents is +22.81% above its 3-year low of $7.28B reached on
ABT annual cash & cash equivalents is higher than 98.64% of companies in Healthcare sector

Cash and Cash Equivalents Chart

SUGGESTED SERIES

Performance

ABT Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$8.94B+12.2%-12.1%+25.1%+22.1%
Quarterly Cash & Cash Equivalents-––––
Price$92.80-28.0%-15.3%-23.8%+270.7%
Annual Current Assets$26.00B+9.9%+3.1%+27.2%+16.5%
Annual Total Liabilities$33.94B+1.3%-9.6%-14.2%-10.2%
Annual Working Capital$9.50B+0.0%-2.4%+11.3%+87.9%
Annual Net Income$6.50B-51.3%-5.9%+46.1%+40.9%

Cash and Cash Equivalents Highs

ABT Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$10.17BN/A-12.1%
5Y$10.25B-12.8%
All$18.78B-52.4%

Cash and Cash Equivalents Lows

ABT Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$7.28B+22.8%
5Y$7.15BN/A+25.1%
All$48.67M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$8.94B+12.2%
$7.97B+9.5%
$7.28B-28.4%
$10.17B-0.8%
$10.25B+43.4%
$7.15B+72.7%
$4.14B+1.3%
$4.09B-57.5%
$9.61B-48.8%
$18.78B+206.5%
$6.13B+37.3%
$4.46B-44.9%
$8.10B-46.6%
$15.17B+87.4%
$8.10B+10.6%
$7.32B-26.3%
$9.93B+95.5%
$5.08B+80.1%
$2.82B+105.4%
$1.37B-53.5%
YearValueChange
$2.96B+43.6%
$2.06B+60.1%
$1.29B+33.2%
$966.13M+35.4%
$713.54M-38.3%
$1.16B+59.9%
$723.30M+88.7%
$383.32M+48.0%
$259.01M+110.4%
$123.08M-61.0%
$315.70M+0.1%
$315.33M-16.8%
$378.83M+46.7%
$258.18M+76.6%
$146.23M+175.1%
$53.15M+9.2%
$48.67M-91.6%
$582.65M+12.1%
$519.93M+300.9%
$129.68M-

FAQ

  • What is the current annual cash & cash equivalents of ABT?

    As of today, ABT annual cash & cash equivalents is $8.94B

  • What is 1-year change in ABT annual cash & cash equivalents?

    ABT annual cash & cash equivalents is up +12.20% year-over-year

  • What is 3-year change in ABT annual cash & cash equivalents?

    ABT annual cash & cash equivalents is down -12.10% over the past 3 years

  • How far is ABT annual cash & cash equivalents from its all-time high?

    ABT annual cash & cash equivalents is currently -52.39% below its historical high of $18.78B set on December 31, 2016

  • How does ABT annual cash & cash equivalents rank versus sector peers?

    ABT annual cash & cash equivalents is higher than 98.64% of companies in Healthcare sector

  • When is ABT next annual earnings release?

    As of today, the next annual earnings release for ABT has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. ABT Official Website www.abbott.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm
  3. ABT Profile on Yahoo Finance finance.yahoo.com/quote/ABT
  4. ABT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/abt